Neoadjuvant Ipilimumab in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab + Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Immunotherapy to Treat Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE1